289 related articles for article (PubMed ID: 19329323)
21. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
22. 1,6-Dihydro-2H-indeno[5,4-b]furan derivatives: design, synthesis, and pharmacological characterization of a novel class of highly potent MT₂-selective agonists.
Koike T; Hoashi Y; Takai T; Nakayama M; Yukuhiro N; Ishikawa T; Hirai K; Uchikawa O
J Med Chem; 2011 May; 54(9):3436-44. PubMed ID: 21473625
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
[TBL] [Abstract][Full Text] [Related]
24. The role of proline residues in the structure and function of human MT2 melatonin receptor.
Mazna P; Grycova L; Balik A; Zemkova H; Friedlova E; Obsilova V; Obsil T; Teisinger J
J Pineal Res; 2008 Nov; 45(4):361-72. PubMed ID: 18544139
[TBL] [Abstract][Full Text] [Related]
25. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of a novel series of tricyclic dihydrofuran derivatives: discovery of 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a]pyridines as melatonin receptor (MT1/MT2) ligands.
Koike T; Takai T; Hoashi Y; Nakayama M; Kosugi Y; Nakashima M; Yoshikubo S; Hirai K; Uchikawa O
J Med Chem; 2011 Jun; 54(12):4207-18. PubMed ID: 21568291
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of 1-(2-alkanamidoethyl)-6-methoxy-7-azaindole derivatives as potent melatonin agonists.
Jeanty M; Suzenet F; Delagrange P; Nosjean O; Boutin JA; Caignard DH; Guillaumet G
Bioorg Med Chem Lett; 2011 Apr; 21(8):2316-9. PubMed ID: 21420861
[TBL] [Abstract][Full Text] [Related]
28. New selective ligands of human cloned melatonin MT1 and MT2 receptors.
Audinot V; Mailliet F; Lahaye-Brasseur C; Bonnaud A; Le Gall A; Amossé C; Dromaint S; Rodriguez M; Nagel N; Galizzi JP; Malpaux B; Guillaumet G; Lesieur D; Lefoulon F; Renard P; Delagrange P; Boutin JA
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):553-61. PubMed ID: 12764576
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of benzofuranic derivatives as new ligands at the melatonin-binding site MT3.
Ettaoussi M; Péres B; Klupsch F; Delagrange P; Boutin JA; Renard P; Caignard DH; Chavatte P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 May; 16(9):4954-62. PubMed ID: 18372181
[TBL] [Abstract][Full Text] [Related]
30. 7-Substituted-melatonin and 7-substituted-1-methylmelatonin analogues: effect of substituents on potency and binding affinity.
Faust R; Garratt PJ; Trujillo Pérez MA; Piccio VJ; Madsen C; Stenstrøm A; Frølund B; Davidson K; Teh MT; Sugden D
Bioorg Med Chem; 2007 Jul; 15(13):4543-51. PubMed ID: 17459711
[TBL] [Abstract][Full Text] [Related]
31. An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT(2) melatonin receptor antagonist.
Lucarini S; Bedini A; Spadoni G; Piersanti G
Org Biomol Chem; 2008 Jan; 6(1):147-50. PubMed ID: 18075659
[TBL] [Abstract][Full Text] [Related]
32. 4-Substituted anilides as selective melatonin MT2 receptor agonists.
Epperson JR; Deskus JA; Gentile AJ; Iben LG; Ryan E; Sarbin NS
Bioorg Med Chem Lett; 2004 Feb; 14(4):1023-6. PubMed ID: 15013015
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands.
Sun LQ; Chen J; Takaki K; Johnson G; Iben L; Mahle CD; Ryan E; Xu C
Bioorg Med Chem Lett; 2004 Mar; 14(5):1197-200. PubMed ID: 14980664
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in melatonin receptor ligands.
Zlotos DP
Arch Pharm (Weinheim); 2005 Jun; 338(5-6):229-47. PubMed ID: 15952241
[TBL] [Abstract][Full Text] [Related]
35. Towards the development of mixed MT(1)-agonist/MT(2)-antagonist melatonin receptor ligands.
Spadoni G; Bedini A; Guidi T; Tarzia G; Lucini V; Pannacci M; Fraschini F
ChemMedChem; 2006 Oct; 1(10):1099-105. PubMed ID: 16955531
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
Li G; Zhou H; Jiang Y; Keim H; Topiol SW; Poda SB; Ren Y; Chandrasena G; Doller D
Bioorg Med Chem Lett; 2011 Feb; 21(4):1236-42. PubMed ID: 21237644
[TBL] [Abstract][Full Text] [Related]
37. Ligand binding to the human MT2 melatonin receptor: the role of residues in transmembrane domains 3, 6, and 7.
Mazna P; Berka K; Jelinkova I; Balik A; Svoboda P; Obsilova V; Obsil T; Teisinger J
Biochem Biophys Res Commun; 2005 Jul; 332(3):726-34. PubMed ID: 15913560
[TBL] [Abstract][Full Text] [Related]
38. Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding.
Mazna P; Obsilova V; Jelinkova I; Balik A; Berka K; Sovova Z; Ettrich R; Svoboda P; Obsil T; Teisinger J
J Neurochem; 2004 Nov; 91(4):836-42. PubMed ID: 15525337
[TBL] [Abstract][Full Text] [Related]
39. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
40. High-throughput screening assay for new ligands at human melatonin receptors.
Yan JH; Su HR; Boutin JA; Renard MP; Wang MW
Acta Pharmacol Sin; 2008 Dec; 29(12):1515-21. PubMed ID: 19026172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
